Filters
Results 1 - 10 of 4128
Results 1 - 10 of 4128.
Search took: 0.028 seconds
Sort by: date | relevance |
AbstractAbstract
No abstract available
Primary Subject
Source
Letter to the editor.
Record Type
Journal Article
Journal
British Journal of Radiology; ISSN 0007-1285;
; v. 57(683); p. 1044

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
No abstract available
Primary Subject
Source
Letter to the editor.
Record Type
Journal Article
Journal
Canadian Journal of Surgery; ISSN 0008-428X;
; v. 26(1); p. 14-19

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Trindade, M.C.; Patricio, M.B.; Jorge, L.; Vilhena, M. de.
Proceedings of the 2. Iberian-American Congress of Oncology1988
Proceedings of the 2. Iberian-American Congress of Oncology1988
AbstractAbstract
[en] Published in summary form only
Original Title
Revisao retrospectiva dos melanomas tratados no Departamento de Radioterapia do Centro de Lisboa do Instituto Portugues de Oncologia de Francisco Gentil (IPOFG), durante 25 anos
Primary Subject
Source
Sociedade Brasileira de Cancerologia, Salvador, BA (Brazil); 156 p; 1988; p. 100; 2. Iberian-American Congress of Oncology; Salvador, BA (Brazil); 9-14 Oct 1988
Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
LanguageLanguage
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] The hypoxic cell sensitizer Ro 03-8799 has been given with radiotherapy to achieve complete and sustained regression in 5 of 7 cases of recurrent malignant melanoma treated with the object of cure and in 1 of 3 treated palliatively. Particularly high tumour concentrations of this radiosensitizing drug have been found in 3 of 6 cases studied. 9 refs.; 2 figs.; 2 tabs
Primary Subject
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Melanoma is the most malignant cutaneous tumor. In the present time, sentinel node biopsy is a standard of care in patients with thickness of primary lesion more than 1 mm. Authors present a case report of a patient after excision of cutaneuos tumor from the right shoulder which was initially histopathologically diagnosed as melanoma in situ. This patient developed after eight years regional supraclavicular and axillary lymphadenopathy, and therefore the histopathological examination of the specimen was revised. This revision classified the primary tumor as a superficial spreading melanoma Breslow 0.9 mm, Clark III with mitotic rate of 5 mitoses/1 mm2. On the basis of the histopathologic finding of metastatic involvement of the supraclavicular lymph node a complete dissection of the right axillary lymph nodes was performed. Metastases were present in all dissected axillary lymph nodes. Authors discuss individual consideration for offering sentinel node biopsy to patients with melanoma of thickness less than 1 mm if risk factors such as mitotic rate equal to or more than 1 mitosis/1 mm2 and ulceration are present. (author)
Original Title
Vyznam sentinelovej biopsie v chirurgickej liecbe tenkeho maligneho melanomu - kazuistika
Primary Subject
Source
Available on-line http://www.solen.sk/index.php?page=pdf_view&pdf_id=6224&magazine_id=17; 12 refs.
Record Type
Journal Article
Journal
Slovenska chirurgia; ISSN 1336-5975;
; v. 10(1); p. 35-36

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Choroidal malignant melanomas are relatively rare tumours and can have a very long natural history. The management of these tumours is controversial. The results of a study of a small group of patients treated by radiotherapy, either as primary treatment or following local excision or enucleation, are presented here. The value of radical radiotherapy in the management of choroidal malignant melanoma is discussed. (author)
Primary Subject
Secondary Subject
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Filippi, Andrea Riccardo; Fava, Paolo; Badellino, Serena; Astrua, Chiara; Ricardi, Umberto; Quaglino, Pietro, E-mail: andreariccardo.filippi@unito.it2016
AbstractAbstract
[en] Introduction: The therapeutic landscape of metastatic melanoma drastically changed after the introduction of targeted therapies and immunotherapy, in particular immune checkpoints inhibitors (ICI). In recent years, positive effects on the immune system associated to radiotherapy (RT) were discovered, and radiation has been tested in combination with ICI in both pre-clinical and clinical studies (many of them still ongoing). We here summarize the rationale and the preliminary clinical results of this approach. Materials and methods: In the first part of this review article, redacted with narrative non-systematic methodology, we describe the clinical results of immune checkpoints blockade in melanoma as well as the biological basis for the combination of ICI with RT; in the second part, we systematically review scientific publications reporting on the clinical results of the combination of ICI and RT for advanced melanoma. Results: The biological and mechanistic rationale behind the combination of ICI and radiation is well supported by several preclinical findings. Retrospective observational series and few prospective trials support the potential synergistic effect between radiation and ICI for metastatic melanoma. Conclusion: RT may potentiate anti-melanoma activity of ICI by enhancing response on both target and non-target lesions. Several prospective trials are ongoing with the aim of further exploring this combination in the clinical setting, hopefully confirming initial observations and opening a new therapeutic window for advanced melanoma patients.
Primary Subject
Source
S0167-8140(16)31150-1; Available from http://dx.doi.org/10.1016/j.radonc.2016.06.003; Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Garge, Shaileshkumar; Mani, Sunithi; Inbaraj, Alfred; Rajshekhar, Vedantam; Mohapatra, Priyanka, E-mail: drshaileshgarge@gmail.com2017
AbstractAbstract
[en] Primay melanoma of the cavernous sinus is very rare with only few cases reported in the literature. We present the cross-sectional imaging findings of this rare tumor. The differential diagnosis for cavernous sinus mass lesion is wide as it contains vital neurovascular structures that may be affected by vascular, neoplastic, infective, and infiltrative lesions arising in the cavernous sinus proper or via extension from adjacent intra and/or extracranial regions. Radiologic imaging can narrow the differential diagnosis, however, imaging cannot definitely reach single diagnosis if they present in atypical form with hemorrage and cystic degeneration. This case report illustrates that primary cavernous sinus melanoma may present as a atypical tumor with diagnostic dilemma.
Primary Subject
Source
Available from http://dx.doi.org/10.4103/0971-3026.202970; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385773; PMCID: PMC5385773; PMID: 28515583; PUBLISHER-ID: IJRI-27-43; OAI: oai:pubmedcentral.nih.gov:5385773; Copyright: (c) 2017 Indian Journal of Radiology and Imaging; This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.; Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
Indian Journal of Radiology and Imaging - New Series (Print); ISSN 0971-3026;
; v. 27(1); p. 43-45

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Fraction size in radiotherapy of malignant melanoma remains a point of controversy. Among 139 patients treated at the University of Illinois Hospital in 1979-1988, 36 were considered potentially curable (not counting ocular melanomas); 20 were treated by the Princess Margaret Hospital (PMH) hypofractionated schedule using 800 cGy per fraction and achieved a permanency of local control lasting > 6 months since the beginning of radiotherapy in 10/22 (45.5%) courses. Comparable results were obtained in 11 patients treated by standard fractionation to at least threshold curative levels. A modification of PMH regimen in 5 patients (but with 13 courses) by decreasing fraction size to 400 cGy while keeping total dose and course duration unchanged, resulted in a 100% loss of focal control within 6 months. Patients considered incurable and irradiated by PMH schedule responded in 83% of courses compared to 51.4% response rate in patients irradiated with other schedules (except) modified PMH regimen). Other aspects of melanoma management are analyzed. (author) 12 tabs., 3 figs., 32 refs
Primary Subject
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] MRI of uveal melanoma using 1.5-T technology and surface coils has developed into a standard procedure. The purpose of the study was to evaluate the feasibility of 3.0-T technology in eye imaging. To optimize the MRI sequences for clinical eye imaging with 3.0-T, six healthy volunteers were conducted using a 4.0-cm surface coil. Evaluation criteria were the signal-to-noise-ratio (SNR), contrast-to-noise-ratio (CNR) and image quality. A further six patients with uveal melanoma were examined with 1.5- and 3.0-T under retrobulbar anesthesia. During 3.0-T examinations of volunteers, eye movements caused significant artifacts. On the contrary, excellent imaging quality was reached in examinations of patients under retrobulbar anesthesia at 3.0 T. Subjective assessment showed no significant difference between 1.5 and 3.0 T in patients. Due to the increased SNR, the 3.0-T technique has the potential to improve eye imaging, but the higher susceptibility to motion artifacts limits the clinical use of this technique to patients receiving retrobulbar anesthesia. (orig.)
Primary Subject
Source
Available from: http://dx.doi.org/10.1007/s00330-005-0087-z
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
1 | 2 | 3 | Next |